Skip to main content
. Author manuscript; available in PMC: 2022 May 18.
Published in final edited form as: J Am Coll Cardiol. 2021 Nov 23;78(21):2092–2105. doi: 10.1016/j.jacc.2021.09.019

CENTRAL ILLUSTRATION. Cell and Cell Products for Cardiac Repair.

CENTRAL ILLUSTRATION

Postinfarction left ventricular remodeling–associated heart failure results in considerable morbidity and mortality. Current and future treatment strategies will likely involve repeated interventions using cell and cell products such as reprogramming strategies, engineered muscle constructs, and modulation of the cell cycle regulation or immune system responses.